FMP
Aethlon Medical, Inc.
AEMD
NASDAQ
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
0.715 USD
0.0271 (3.79%)
About
ceo
Mr. James B. Frakes M.B.A.
sector
Healthcare
industry
Medical - Devices
exchange
NASDAQ
Description
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
CIK
0000882291
ISIN
US00808Y4061
CUSIP
00808Y307
Address
11555 Sorrento Valley Road
Phone
619 941 0360
Country
US
Employee
14
IPO Date
Mar 4, 1999
Key Executives
